Net Income

Net Income

Eli Lilly Net Income increased by 11.4% to $7.40B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 168.0%, from $2.76B to $7.40B. Over 4 years (FY 2021 to FY 2025), Net Income shows an upward trend with a 38.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionNet Income
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026

How to read this metric

Consistent growth in net income is the primary driver of long-term stock price appreciation and dividend capacity.

Detailed definition

The 'bottom line' profit of the company after all expenses, including interest and taxes, have been deducted from total...

Peer comparison

This is the standard metric for calculating Earnings Per Share (EPS) and Price-to-Earnings (P/E) ratios.

Metric ID: net_income

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.39B$1.11B$1.73B$1.90B$952.50M$1.45B$1.94B$1.34B$1.76B-$57.40M$2.19B$2.24B$2.97B$970.30M$4.41B$2.76B$5.66B$5.58B$6.64B$7.40B
QoQ Change-20.1%+55.5%+10.2%-49.9%+52.4%+33.5%-30.6%+31.1%-103.3%>999%+2.4%+32.3%-67.3%+354.5%-37.4%+105.1%-1.4%+18.9%+11.4%
YoY Change-31.5%+30.8%+12.3%-29.3%+85.1%-104.0%+13.0%+66.8%+68.3%>999%+101.4%+23.0%+90.8%+475.3%+50.5%+168.0%
Range-$57.40M$7.40B
CAGR+42.2%
Avg YoY Growth+175.7%
Median YoY Growth+58.6%
Current Streak2 quarters growth

Business Segments

View all
SegmentQ1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Reportable Segment$2.76B$5.66B$5.58B$6.64B$7.40B
Total$2.76B$5.66B$5.58B$6.64B$7.40B

Frequently Asked Questions

What is Eli Lilly's net income?
Eli Lilly (LLY) reported net income of $7.40B in Q1 2026.
How has Eli Lilly's net income changed year-over-year?
Eli Lilly's net income increased by 168.0% year-over-year, from $2.76B to $7.40B.
What is the long-term trend for Eli Lilly's net income?
Over 4 years (2021 to 2025), Eli Lilly's net income has grown at a 38.7% compound annual growth rate (CAGR), from $5.58B to $20.64B.
What does net income mean?
The final profit of the company after every single expense and tax has been paid.